🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To compare the complete response rate (CR rate) after in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-23
Trial ID
NCT07505849
Treatments Being Tested
In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...
Status
Unknown
Location
Henan cancer hospital
Start Date
2021-05-26
Trial ID
NCT04938297
Treatments Being Tested
As the most common subtype of lymphoma, diffuse large B-cell lymphoma (DLBC...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2021-10-01
Trial ID
NCT05290090
Treatments Being Tested
A multicenter, prospective, randomized, open-label, controlled trial to eva...
Status
Recruiting
Location
Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2024-07-29
Trial ID
NCT06522555
This is a prospective, single-center, open-label clinical study designed to...
Status
Unknown
Location
First Affiliated Hospital of Wenzhou Medical University
Start Date
2022-06-15
Trial ID
NCT05428670
Treatments Being Tested
This is a prospective, single-center, open-label, single-arm clinical study...
Status
Active Not Recruiting
Location
Shanghai Ruijin Hospital
Start Date
2020-08-26
Trial ID
NCT04460248
Treatments Being Tested
A multicenter, prospective, randomized, open-label, controlled trial to eva...
Status
Unknown
Location
Ruijin Hospital
Start Date
2022-03-02
Trial ID
NCT05179733
This is a prospective, open-label, single-arm, single-center, Phase II clin...
Status
Recruiting
Location
Jiangsu Province Hospital
Start Date
2026-02-01
Trial ID
NCT07418190
Treatments Being Tested
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital
Start Date
2026-06-30
Trial ID
NCT07717177
Treatments Being Tested